A federal judge in charge of the multidistrict litigation against Bayer’s product Roundup recently gave Bayer’s legal team until November 2 of this year to finalize the details of its settlements for thousands of people involved in lawsuits against them. The settlement involved a deal close to 11 billion dollars to settle claims in which the plaintiffs contended that use of the herbicide led to cancer. After the deadline passed, the judge’s stay on litigation against Bayer would supposedly expire, allowing him to send remaining lawsuits back to state courts for trials. However, the mediator in the case reported that he expected that all of the cases subject to the settlement deal would successfully be settled by Bayer before the cut-off date. Unfortunately, that did not occur as, on November 3, it was reported that the outstanding lawsuits were not settled. This was significant because it means that the cases kept on hold by the federal judge could move forward, stifling Bayer’s strategies designed to contain them.
The litigation against Bayer is based on the contention that glyphosate, the main ingredient in its popular weed killer, causes cancer. In 2015, the World Health Organization (WHO) made the declaration that glyphosate is a “probable human carcinogen.” Roundup has been used worldwide to the tune of six billion dollars in revenue for the company with more than 250 million pounds of the product sprayed on both public and private property, including farmlands, lawns, parks, gardens, playgrounds, and more.
Have you been diagnosed with cancer due to consistent exposure to Roundup? Talk to one of our experienced personal injury lawyers at (888) 398-2277 today. Your consultation is free.
More About Roundup Litigation
The litigation against Bayer regarding Roundup revolves around the allegations of its side effects. The most serious of these side effects is that of non-Hodgkin’s lymphoma and leukemia. Non-Hodgkin’s lymphoma is a type of cancer that can occur in any part of the human body and originates from white blood cells. Leukemia is a type of cancer that involving tissues that form blood in the body. Those most at risk for these diseases include farm workers and garden center or nursery workers. However, anyone who uses the product may expect an increased potential risk for serious side effects.
The 2015 statement from WHO was based on a report from the International Agency for Research on Cancer (IARC) that found that glyphosate caused cancer in lab animals as well as damage to human cell DNA. Despite these findings, Bayer has continued to produce and sell the product across the U.S. and the world. Many U.S. cities, counties, and states are beginning to put in restrictions against its use. Roundup is also facing legislative restriction in many foreign countries or has been outright banned, such as in Austria and Germany.
Bayer lost its first several litigation cases where juries ruled in favor of the plaintiffs. In one of those, the plaintiff was award $289 million; the jury wholeheartedly agreed that his continued use of Roundup as a groundskeeper led to his diagnosis of non-Hodgkin’s lymphoma. However, the award was later reduced. In two other cases, Bayer lost similarly large amounts when juries ruled in favor of the plaintiffs. After these cases, the settlement deal was struck which has been ongoing for approximately a year.
You Can Still File a Suit Against Bayer
If you have been newly diagnosed with cancer that you believe is a side effect of the use of Roundup, you can still file a lawsuit against Bayer. Your first action is to discuss your case with a knowledgeable attorney at Bertram & Graf, L.L.C. to learn more about if you may qualify to move forward. Our legal team of personal injury lawyers have extensive experience in this field based on a strong history of successful results.
Ready to discuss your case? Contact us at (888) 398-2277 to arrange for your free consultation today.